Document ID: chunk:federal_register_of_legislation:F2025C00215:reg:7
Version: federal_register_of_legislation:F2025C00215
Segment Type: reg
Provision Reference: reg 7
Character Range: 5679–6902

7  Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners
 (1) For the purposes of paragraph 98C(1)(a) of the Act, this section provides for the manner of ascertaining the Commonwealth price for a quantity, or number of units, of a pharmaceutical benefit supplied by an approved medical practitioner, for the purposes of a payment to the practitioner in respect of the supply.
 (2) The Commonwealth price is to be ascertained in the same manner as the Commonwealth price for the supply would have been worked out under the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020) if the supply had been made by an approved pharmacist.
 (3) Schedules 1, 2, 3 and 5 identify pharmaceutical benefits and ingredients in relation to which particular rules for ascertaining the Commonwealth price apply.
Note: Those rules are in the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020), which is relevant because of subsection (2) of this section.

Part 3—Conditions on payments for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners